BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18926575)

  • 1. Quercetin and interferon-beta modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients.
    Sternberg Z; Chadha K; Lieberman A; Hojnacki D; Drake A; Zamboni P; Rocco P; Grazioli E; Weinstock-Guttman B; Munschauer F
    J Neuroimmunol; 2008 Dec; 205(1-2):142-7. PubMed ID: 18926575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory responses of peripheral blood mononuclear cells from multiple sclerosis patients upon in vitro incubation with the flavonoid luteolin: additive effects of IFN-beta.
    Sternberg Z; Chadha K; Lieberman A; Drake A; Hojnacki D; Weinstock-Guttman B; Munschauer F
    J Neuroinflammation; 2009 Oct; 6():28. PubMed ID: 19825164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
    Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
    Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.
    Lalive PH; Kantengwa S; Benkhoucha M; Juillard C; Chofflon M
    J Neuroimmunol; 2008 Jul; 197(2):147-51. PubMed ID: 18555540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1, 25 dihydroxyvitamin D(3) on matrix metalloproteinases MMP-7, MMP-9 and the inhibitor TIMP-1 in pulmonary tuberculosis.
    Anand SP; Selvaraj P
    Clin Immunol; 2009 Oct; 133(1):126-31. PubMed ID: 19615945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.
    Sarchielli P; Critelli A; Greco L; Sokola E; Floridi A; Gallai V
    Cytokine; 2001 Jun; 14(5):294-8. PubMed ID: 11444910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis.
    Yushchenko M; Mäder M; Elitok E; Bitsch A; Dressel A; Tumani H; Bogumil T; Kitze B; Poser S; Weber F
    J Neurol; 2003 Oct; 250(10):1224-8. PubMed ID: 14586607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.
    Kieseier BC; Archelos JJ; Hartung HP
    Arch Neurol; 2004 Jun; 61(6):929-32. PubMed ID: 15210533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with type I interferons induces a regulatory T cell subset in peripheral blood mononuclear cells from multiple sclerosis patients.
    Pentón-Rol G; Cervantes-Llanos M; Cabrera-Gómez JA; Alonso-Ramírez R; Valenzuela-Silva C; Rodríguez-Lara R; Montero-Casimiro E; Bello-Rivero I; López-Saura P
    Int Immunopharmacol; 2008 Jun; 8(6):881-6. PubMed ID: 18442793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.
    Dressel A; Kolb AK; Elitok E; Bitsch A; Bogumil T; Kitze B; Tumani H; Weber F
    Acta Neurol Scand; 2006 Dec; 114(6):368-73. PubMed ID: 17083335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients.
    Brudek T; Christensen T; Hansen HJ; Petersen T; Møller-Larsen A
    Scand J Immunol; 2008 Mar; 67(3):295-303. PubMed ID: 18261041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.
    Bernal F; Elias B; Hartung HP; Kieseier BC
    Mult Scler; 2009 Jun; 15(6):721-7. PubMed ID: 19383643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
    Singh MK; Scott TF; LaFramboise WA; Hu FZ; Post JC; Ehrlich GD
    J Neurol Sci; 2007 Jul; 258(1-2):52-9. PubMed ID: 17467740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of season on cytokine expression in multiple sclerosis and healthy subjects.
    Stewart N; Taylor B; Ponsonby AL; Pittas F; van der Mei I; Woods G; Walters H
    J Neuroimmunol; 2007 Aug; 188(1-2):181-6. PubMed ID: 17628701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-beta: mechanism of action and dosing issues.
    Markowitz CE
    Neurology; 2007 Jun; 68(24 Suppl 4):S8-11. PubMed ID: 17562848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
    Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S
    Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosis.
    Angelucci F; Mirabella M; Caggiula M; Frisullo G; Patanella K; Sancricca C; Nociti V; Tonali PA; Batocchi AP
    Peptides; 2005 Nov; 26(11):2289-93. PubMed ID: 16269354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of beta-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis.
    Hedegaard CJ; Krakauer M; Bendtzen K; Sørensen PS; Sellebjerg F; Nielsen CH
    Clin Immunol; 2008 Oct; 129(1):80-9. PubMed ID: 18653385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory properties of Achyrocline satureioides (Lam.) D.C. infusion: a study on human leukocytes.
    Cosentino M; Bombelli R; Carcano E; Luini A; Marino F; Crema F; Dajas F; Lecchini S
    J Ethnopharmacol; 2008 Mar; 116(3):501-7. PubMed ID: 18280072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.